Lacosamide: Difference between revisions
| [pending revision] | [pending revision] |
MDElliottMD (talk | contribs) Comprehensive categorization: +Sodium channel blockers |
MDElliottMD (talk | contribs) Category taxonomy ship: retag Anticonvulsants -> Antiepileptics |
||
| (One intermediate revision by the same user not shown) | |||
| Line 31: | Line 31: | ||
}} | }} | ||
[[Category:Antiepileptics]] | |||
[[Category: | |||
[[Category:Sodium channel blockers]] | [[Category:Sodium channel blockers]] | ||
Latest revision as of 00:36, 22 May 2026
Anticonvulsant
Lacosamide
Vimpat
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Interactions
No interactions reported yet.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
Anticonvulsant
Common uses
Pharmacy
Pharmacology
Purported mechanism
Slow-inactivation sodium channel enhancer; CRMP-2 ligand